First- and second-generation antipsychotics: learning from CUtLASS and CATIE.
Rajiv
R
Tandon
William T
WT
Carpenter
John M
JM
Davis
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D019964:Mood Disorders / Q000139:chemically induced; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data*; D012559:Schizophrenia / Q000188:drug therapy; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D003024:Clozapine